½ÃÀ庸°í¼
»óÇ°ÄÚµå
1505169
¼¼°èÀÇ ½ÉÇ÷°ü¿ë µðÁöÅÐ Çコ ½ÃÀå(2024-2031³â)Global Digital Health For Cardiovascular Market 2024-2031 |
¼¼°è ½ÉÇ÷°ü¿ë µðÁöÅÐ Çコ ½ÃÀå ±Ô¸ð´Â 2024-2031³âÀÇ ¿¹Ãø ±â°£ µ¿¾È ¿¬Æò±Õ 22.4%ÀÇ ¼ºÀå·üÀ» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ½ÉÇ÷°ü¿ë µðÁöÅÐ °Ç°Àº ½ÉÀå ¹× Ç÷°ü ÁúȯÀÇ ¿¹¹æ, Áø´Ü ¹× °ü¸®¸¦ °³¼±Çϱâ À§ÇØ ±â¼úÀ» È°¿ëÇÏ´Â ºÐ¾ßÀÔ´Ï´Ù. µµ±¸¿Í ¼ºñ½º¿¡´Â ¿þ¾î·¯ºí ±â±â, ¸ð¹ÙÀÏ °Ç° ¾Û, ¿ø°Ý ÀÇ·á, ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µ µîÀÌ Æ÷ÇԵ˴ϴÙ. ¿þ¾î·¯ºí ±â±â´Â ½É¹Ú¼ö, Ç÷¾Ð, È°µ¿·®À» ¸ð´ÏÅ͸µÇÏ°í, ¸ð¹ÙÀÏ °Ç° ¾ÛÀº Áõ»ó, Åõ¾à, °æ°ú¸¦ ÃßÀûÇÕ´Ï´Ù. ¿ø°Ý ÀÇ·á´Â ¿ø°ÝÁö¿¡¼ ÀÇ»çÀÇ Áø·á¸¦ ¹ÞÀ» ¼ö ÀÖ°í, ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µÀº Àǻ簡 ¿ø°ÝÁö¿¡¼ °Ç° µ¥ÀÌÅ͸¦ ¸ð´ÏÅ͸µÇÒ ¼ö ÀÖ°Ô ÇØÁÝ´Ï´Ù. ÀÌ ±â¼úÀº »îÀÇ ÁúÀ» Çâ»ó½ÃÅ°°í ÀÇ·áºñ¸¦ Àý°¨ÇÒ ¼ö ÀÖ½À´Ï´Ù.
½ÃÀå ¿ªÇÐ
¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µ¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡
Äڷγª19·Î ÀÎÇØ ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µ(RPM) ±â¼úÀÇ Ã¤ÅÃÀÌ °¡¼Óȵǰí ÀÖÀ¸¸ç, RPMÀ» ÅëÇØ ÀÇ·áÁøÀº üÁß, Ç÷¾Ð, Ç÷´ç µî ȯÀÚÀÇ °Ç° µ¥ÀÌÅ͸¦ ¿ø°ÝÀ¸·Î ¸ð´ÏÅ͸µÇÒ ¼ö ÀÖ½À´Ï´Ù. À̸¦ ÅëÇØ ÀáÀçÀûÀÎ ¹®Á¦¸¦ Á¶±â¿¡ ¹ß°ßÇÏ°í ÇØ°áÇÏ¿© ȯÀÚ °á°ú¸¦ °³¼±ÇÏ°í ÀÇ·á ºñ¿ëÀ» Àý°¨ ÇÒ ¼ö ÀÖ½À´Ï´Ù.
½ÃÀå ¼¼ºÐÈ
¼¼°è ½ÉÇ÷°ü¿ë µðÁöÅÐ Çコ ½ÃÀåÀº ºÏ¹Ì(¹Ì±¹, ij³ª´Ù), À¯·´(¿µ±¹, ÀÌÅ»¸®¾Æ, ½ºÆäÀÎ, µ¶ÀÏ, ÇÁ¶û½º, ±âŸ À¯·´), ¾Æ½Ã¾ÆÅÂÆò¾ç(Àεµ, Áß±¹, ÀϺ», Çѱ¹, ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç), ±âŸ Áö¿ª(Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«, Áß³²¹Ì) µî Áö¿ªº°·Î ¼¼ºÐȵǾî ÀÖ½À´Ï´Ù. ¼¼ºÐȵ˴ϴÙ.
ºÏ¹Ì°¡ ÁÖ¿ä ½ÃÀå Á¡À¯À²À» Â÷ÁöÇÕ´Ï´Ù.
ºÏ¹Ì´Â ºü¸¥ ±â¼ú µµÀÔ, ¼±ÁøÈµÈ ÀÇ·á ½Ã½ºÅÛ, ¾çÈ£ÇÑ ±ÔÁ¦ ȯ°æ, ½ÉÇ÷°ü Áúȯ¿¡ ´ëÇÑ ³ôÀº ºÎ´ã, ºñ¿ë Àý°¨¿¡ ´ëÇÑ °ü½É µîÀ¸·Î ÀÎÇØ Å« Á¡À¯À²À» Â÷ÁöÇÏ°í ÀÖ½À´Ï´Ù. ¼±ÁøÈµÈ ÀÇ·á ½Ã½ºÅÛ, ÀÇ·á ±â°ü°ú À¯´ÉÇÑ Àü¹®°¡µéÀÇ ÁýÀû, °£¼ÒÈµÈ ±ÔÁ¦ ÇÁ·Î¼¼½º·Î ÀÎÇØ µðÁöÅÐ Çコ ¼Ö·ç¼Ç µµÀÔ¿¡ À¯¸®ÇÑ È¯°æÀÌ Á¶¼ºµÇ¾î ÀÖ½À´Ï´Ù.
¼¼°è ½ÉÇ÷°ü¿ë µðÁöÅÐ Çコ ½ÃÀå¿¡ ÁøÃâÇÑ ÁÖ¿ä ±â¾÷À¸·Î´Â Siemens Healthineers AG, Oracle(Cerner Corporation), Apple Inc. ½ÃÀå °æÀï·ÂÀ» À¯ÁöÇϱâ À§ÇØ ½ÃÀå ±â¾÷µéÀº Á¦ÈÞ, ÇÕº´, Àμö µîÀÇ Àü·«À» Àû¿ëÇÏ¿© »ç¾÷ È®Àå ¹× Á¦Ç° °³¹ß¿¡ Á¡Á¡ ´õ ¸¹Àº ³ë·ÂÀ» ±â¿ïÀÌ°í ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, 2024³â 3¿ù »ï¼ºÀÇ ÀÚȸ»ç À£¸®½º(Wellysis)´Â ¹Ì±¹¿¡¼ ¿ø°Ý ½ÉÀå ¸ð´ÏÅ͸µ ¼ºñ½º¸¦ Ãâ½ÃÇϱâ À§ÇØ ¾Æ¸£ÅÚ¶ó ¼Ö·ç¼Ç(Artella Solutions, ARTELLA)°ú Á¦ÈÞ¸¦ ¸Î¾ú½À´Ï´Ù. ÀÌ Á¦ÈÞ´Â 10 °³ ÁÖ¿¡ °ÉÃÄ ARTELLAÀÇ FDA ÀÎÁõÀ» ¹ÞÀº S-Patch ½ÉÀüµµ ¸ð´ÏÅ͸µ ¼Ö·ç¼ÇÀ» Á¦°øÇÏ´Â °ÍÀ» ¸ñÇ¥·Î ÇÏ°í ÀÖ½À´Ï´Ù.
Digital Health For Cardiovascular Market Size, Share & Trends Analysis Report by Component (Hardware, Software, and Services), by End-User (Patients, Payers, Providers and Other) Forecast Period (2024-2031)
Digital health for cardiovascular market is anticipated to grow at a CAGR of 22.4% during the forecast period (2024-2031). Digital health for cardiovascular disorders is a field that uses technology to improve the prevention, diagnosis, and management of heart and blood vessel diseases. Tools and services include wearable devices, mobile health apps, telemedicine, and remote patient monitoring. Wearable devices monitor heart rate, blood pressure, and activity levels, while mobile health apps track symptoms, medications, and progress. Telemedicine allows remote doctor visits, while remote patient monitoring allows doctors to monitor health data remotely. This technology can improve quality of life and reduce healthcare costs.
Market Dynamics
Growing Demand for Remote Patient Monitoring
The COVID-19 pandemic has accelerated the adoption of remote patient monitoring (RPM) technologies. RPM allows healthcare providers to monitor patients' health data remotely, such as weight, blood pressure, and blood sugar levels. This can help to identify and address potential problems early on, improving patient outcomes and reducing healthcare costs. For instance, in March 2024, Wellysis, a subsidiary of Samsung, collaborated with Artella Solutions (ARTELLA) to introduce a remote cardiac monitoring service.
Market Segmentation
The global digital health for cardiovascular market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia-Pacific), and the Rest of the World (the Middle East & Africa, and Latin America).
North America Holds Major Market Share
North America holds a significant share driven by the rapid technology adoption, advanced healthcare systems, favorable regulatory landscape, high burden of cardiovascular disease, and focus on cost reduction. The country's advanced healthcare systems, a high concentration of medical institutions and qualified professionals, and streamlined regulatory processes make it a favorable environment for adopting digital health solutions.
The major companies serving the global digital health for the cardiovascular market include Siemens Healthineers AG, Oracle (Cerner Corporation), Apple Inc., Wellysis, and HeartFlow, Inc. among others. The market players are increasingly focusing on business expansion and product development by applying strategies such as collaborations, mergers, and acquisitions to stay competitive in the market. For instance, in March 2024, Wellysis, a Samsung subsidiary, teamed up with Artella Solutions (ARTELLA) to unveil its remote cardiac monitoring service in the US. This partnership aims to offer the FDA-cleared S-Patch electrocardiogram monitoring solution from ARTELLA across ten states.